House Democrats Miss the Mark on Drug Pricing
The Big Picture This week, the House Committees on Energy and Commerce (E&C) and Ways and Means (W&M) marked up their portion of the reconciliation package for fiscal year 2022.
FreedomWorks Leads Letter to Oklahoma Senate Opposing Prescription Drug Price Controls in SB 734
Today, FreedomWorks President Adam Brandon sent a letter alongside 190 of our Oklahoma activists to the Oklahoma State Senate in strong opposition to Senate Bill 734: An Act relating to…
Regulatory Action Center Review – October 8, 2020
Welcome to the new and improved Regulatory Action Center (RAC) Review! RAC proudly keeps you up to date on what we’re up to and what we’re keeping our eyes on…
FreedomWorks Launches International Reference Pricing Scorecard
FreedomWorks Foundation’s Regulatory Action Center (RAC) has launched a scorecard for the 16 nations to which the Department of Health and Human Services (HHS) wants to tie the United…
Regulatory Action Center Review – September 24, 2020
Welcome to the new and improved Regulatory Action Center (RAC) Review! RAC proudly keeps you up to date on what we’re up to and what we’re keeping our eyes on…
Fact Checking on Trump’s Price Control Executive Order
On Friday, President Trump issued three executive orders (and threatened a fourth) outlining sweeping changes he planned to make regarding prescription drug prices in the United States. One order seeks…
Price Controls Aren’t Solutions
Prices for prescription drugs in the U.S. are far too high. There is no denying this sad reality. According to an analysis done by the House Ways and Means Committee,…
Regulatory Action Center Review – July 1, 2020
Welcome to the new and improved Regulatory Action Center (RAC) Review! RAC proudly keeps you up to date on what we’re up to and what we’re keeping our eyes…
Key Vote NO on Speaker Pelosi’s Socialist Drug Price Fixing Plan, H.R. 3
On behalf of FreedomWorks’ activist community, I urge you to contact your representative and urge him or her to vote NO on Speaker Nancy Pelosi’s Socialist Drug Price Fixing Plan,…
H.R. 3: The “No New Cures Ever” Act
In the coming weeks, Speaker Nancy Pelosi’s (D-Calif.) priority drug pricing bill, H.R. 3, is expected to come up for a vote in the House of Representatives. Make no…